High-Throughput Screening for Human Lysosomal β-N-Acetyl Hexosaminidase Inhibitors Acting as Pharmacological Chaperones

The Metabolic and Molecular Bases of Inherited Disease

Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101 · see citing works

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · see citing works

Structural and sequence-based classification of glycoside hydrolases

Henrissat, B., & Davies, G. J. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80072-3 · Cited by 1,668 · see citing works

Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Hasilík, A., & Neufeld, E. F. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85585-0 · Cited by 803 · see citing works

Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor

Fan, J., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 616 · see citing works

Chemical chaperones increase the cellular activity of N370S β-glucosidase: A therapeutic strategy for Gaucher disease

Sawkar, A. R., Cheng, W., Beutler, E., Wong, C., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 508 · see citing works

Glycosidase mechanisms

Rye, C. S., & Withers, S. G. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00135-6 · Cited by 470 · see citing works

Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues

Hasilik, A., & Neufeld, E. F. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85586-2 · Cited by 400 · see citing works

O-GlcNAcase Uses Substrate-assisted Catalysis

Macauley, M. S., Whitworth, G. E., Debowski, A. W., Chin, D., & Vocadlo, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413819200 · Cited by 378 · see citing works

The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR

Du, K., Sharma, M., & Lukacs, G. L. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb882 · Cited by 356 · see citing works

Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay–Sachs disease

Tews, I., Anastassis Perrakis, A., Oppenheim, A. B., Dauter, Z., Wilson, K. S., & Vorgias, C. E. (1996) · Nature Structural Biology · doi:10.1038/nsb0796-638 · Cited by 342 · see citing works

Pharmacological chaperones: potential treatment for conformational diseases

Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 285 · see citing works

Naphthalimides as Anticancer Agents: Synthesis and Biological Activity

BRANA, M. F., & Ramos, A. (2001) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011013354624 · Cited by 282 · see citing works

A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants

Friedler, A., Hansson, L. O., Veprintsev, D. B., Freund, S. M. V., Rippin, T. M., Nikolova, P. V., Proctor, M. R., Rüdiger, S., & Fersht, A. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241629998 · Cited by 268 · see citing works

Chemical chaperone therapy for brain pathology in G M1 -gangliosidosis

Matsuda, J., Suzuki, O., Oshima, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536657100 · Cited by 264 · see citing works

Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase

Mark, B. L., Vocadlo, D. J., Knapp, S., Triggs‐Raine, B. L., Withers, S. G., & James, M. N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011067200 · Cited by 257 · see citing works

Pharmacologic Rescue of Conformationally‐Defective Proteins: Implications for the Treatment of Human Disease

Ulloa‐Aguirre, A., Janovick, J. A., Brothers, S. P., & Conn, P. M. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00232.x · Cited by 252 · see citing works

NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation

Knapp, S., Vocadlo, D. J., Gao, Z., Kirk, B. A., Lou, J., & Withers, S. G. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960826u · Cited by 248 · see citing works

In vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase A activity in Fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives

Asano, N., Ishii, S., Kizu, H., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 245 · see citing works

A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

Fan, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00158-5 · Cited by 232 · see citing works

Crystal Structure of Human β-Hexosaminidase B: Understanding the Molecular Basis of Sandhoff and Tay–Sachs Disease

Mark, B. L., Mahuran, D. J., Cherney, M. M., Zhao, D., Knapp, S., & James, M. N. G. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00216-x · Cited by 224 · see citing works

Enzymes of Lipid Metabolism II

Freysz, L., Dreyfus, H., Massarelli, R., et al. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5212-9 · Cited by 206 · see citing works

High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase

Blanchard, J., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., & Brown, E. D. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.011 · Cited by 205 · see citing works

Selective Optimization of Side Activities: Another Way for Drug Discovery

Wermuth, C. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030480f · Cited by 202 · see citing works

Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients

Tropak, M. B., Reid, S. P., Guiral, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308523200 · Cited by 200 · see citing works

Crystallographic Structure of Human β-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of GM2 Ganglioside Hydrolysis

Lemieux, M. J., Mark, B. L., Cherney, M. M., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.004 · Cited by 195 · see citing works

Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles

Sawkar, A. R., Adamski‐Werner, S. L., Cheng, W., Wong, C., Beutler, E., Zimmer, K., & Kelly, J. W. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.007 · Cited by 182 · see citing works

Intracellular Protein Degradation: From a Vague Idea, through the Lysosome and the Ubiquitin–Proteasome System, and onto Human Diseases and Drug Targeting (Nobel Lecture)

Ciechanover, A. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501428 · Cited by 180 · see citing works

A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder

Yam, G. H., Zuber, C., & Roth, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2375com · Cited by 163 · see citing works

The GM2 Gangliosidoses

Charria-Ortiz, G. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_16 · Cited by 132 · see citing works

Pharmacological chaperone action on G-protein-coupled receptors

Bernier, V., Bichet, D. G., & Bouvier, M. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.001 · Cited by 130 · see citing works

The X-ray Crystal Structure of Human β-Hexosaminidase B Provides New Insights into Sandhoff Disease

Maier, T., Sträter, N., Schuette, C. G., Klingenstein, R., Sandhoff, K., & Saenger, W. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00311-5 · Cited by 116 · see citing works

Novel Five‐Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis

Liang, P., Cheng, W., Lee, Y.-L., Yu, H., Wu, Y., Lin, Y., & Wong, C. (2006) · ChemBioChem · doi:10.1002/cbic.200500321 · Cited by 109 · see citing works

Rescue of Vasopressin V2 Receptor Mutants by Chemical Chaperones: Specificity and Mechanism

Robben, J. H., Sze, M., Knoers, N. V. A. M., & Deen, P. M. T. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0579 · Cited by 99 · see citing works

The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis

Mahuran, D. J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90044-a · Cited by 98 · see citing works

Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery

Shoemaker, R., Scudiero, D. A., Melillo, G., Currens, M. J., Monks, A. P., Rabow, A. A., Covell, D. G., & Sausville, E. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394317 · Cited by 91 · see citing works

Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders

Diettrich, O., Mills, K. A., Johnson, A., Hasilík, A., & WINCHESTER, B. G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01578-6 · Cited by 83 · see citing works

Synthesis and High-Throughput Screening of N-Acetyl-β-hexosaminidase Inhibitor Libraries Targeting Osteoarthritis

Liu, J., Numa, M. M. D., Liu, H., et al. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo049355h · Cited by 77 · see citing works

Direct Determination of the Substrate Specificity of the α-Active Site in Heterodimeric β-Hexosaminidase A

Hou, Y., Tse, R., & Mahuran, D. J. (1996) · Biochemistry · doi:10.1021/bi9524575 · Cited by 70 · see citing works

High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate

Zolli‐Juran, M., Cechetto, J. D., Hartlen, R., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00480-3 · Cited by 69 · see citing works

N-Acetylglucosaminidase (chitobiase) from Serratia marcescens: gene sequence, and protein production and purification in Escherichia coli

Tews, I., Vincentelli, R., & Vorgias, C. E. (1996) · Gene · doi:10.1016/0378-1119(95)00848-9 · Cited by 68 · see citing works

Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency.

d’Azzo, A., Proia, R. L., Kolodny, E. H., et al. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90623-x · Cited by 66 · see citing works

Bis-naphthalimides: a new class of antitumor agents.

BRANA, M. F., Castellano, J. M., Morán, M., de Vega, M. J. P., Romerdahl, C., Qian, X.-D., Bousquet, P. F., Emling, F., Schlick, E., & Keilhauer, G. (1993) · PubMed · Cited by 55 · see citing works

Biochemical Basis of Late-Onset Neurolipidoses

Conzelmann, E., & Sandhoff, K. (1991) · Developmental Neuroscience · doi:10.1159/000112160 · Cited by 52 · see citing works

Mechanisms of Dimethyl Sulfoxide Augmentation of IL-1β Production

Xing, L., & Remick, D. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6195 · Cited by 48 · see citing works

Synthesis and Inhibitory Properties of 2-Acetamido-2-Deoxynojirimycin (2-Acetamido-5-amino-2,5-dideoxy-D-glucopyranose,1) and 2-Acetamido-1,2-dideoxynojirimycin (2-Acetamido-1,5-imino-1,2,5-trideoxy-D-Glucitol, 2)

Kappes, E., & Legler, G. (1989) · Journal of Carbohydrate Chemistry · doi:10.1080/07328308908048567 · Cited by 48 · see citing works

beta-Hexosaminidase isozymes from cells cotransfected with alpha and beta cDNA constructs: analysis of the alpha-subunit missense mutation associated with the adult form of Tay-Sachs disease.

Brown, C. A., & Mahuran, D. J. (1993) · PubMed · Cited by 43 · see citing works

Aldose Reductase Inhibitors: An Update

Tsai, S. C., & Burnakis, T. G. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700616 · Cited by 40 · see citing works

Evaluation of a Minimal Experimental Design for Determination of Enzyme Kinetic Parameters and Inhibition Mechanism

Kakkar, T., Pak, Y., & Mayersohn, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39308-5 · Cited by 37 · see citing works

Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies

Villalona-Calero, M. A., Eder, J. P., Toppmeyer, D., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.857 · Cited by 37 · see citing works

Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.

Bayleran, J. K., Hechtman, P., Kolodny, E. H., et al. (1987) · PubMed · Cited by 26 · see citing works

Translation initiation in the HEXB gene encoding the beta-subunit of human beta-hexosaminidase.

Neote, K. S., Brown, C. A., Mahuran, D. J., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45286-0 · Cited by 26 · see citing works

A Pro504 → Ser Substitution in the β-Subunit of β-Hexosaminidase A Inhibits α-Subunit Hydrolysis of GM2Ganglioside, Resulting in Chronic Sandhoff Disease

Hou, Y., McInnes, B., Hinek, A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21386 · Cited by 26 · see citing works

GM1-gangliosidosis (Type II): Studies on a fibroblast cell strain

Callahan, J. W., Pinsky, L., & Wolfe, L. S. (1970) · Biochemical Medicine · doi:10.1016/0006-2944(70)90056-6 · Cited by 23 · see citing works

A Decade of Developments in Diuretic Drug Therapy

Hutcheon, D. E., & Martinez, J. C. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb02951.x · Cited by 17 · see citing works

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

Awada, A. H., Thödtmann, R., Piccart, M. J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00776-1 · Cited by 15 · see citing works

A continuous fluorimetric assay for glycosidase activity: Human N-acetyl-β-d-hexosaminidase

Shulman, M. L., Kulshin, V. A., & Khorlin, A. Y. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90198-0 · Cited by 9 · see citing works

Molecular Heterogeneity in O-Variant GM2 Gangliosidosis

O’Dowd, B. F., Klavins, M. H., Willard, H. F., et al. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5212-9_92 · Cited by 2 · see citing works

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review

De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20 · see citing works

GM2 Gangliosidosis with Hexosaminidase A and B Defect: Report of a Family with Motor Neuron Disease-like Phenotype

Federico, A., Ciacci, G., D'Amore, I., et al. (1986) · Springer eBooks · doi:10.1007/978-94-009-4131-1_56 · Cited by 1 · see citing works

Clinical and genetic variations in the syndrome of adult GM2 gangliodosis resulting from hexosaminidase a deficiency

Argov, Z., & Navon, R. (1984) · Annals of Neurology · doi:10.1002/ana.410160105 · Cited by 113 · see citing works

Detection of GM2-gangliosidosis (Tay-sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay

Molzer, B., & Bernheimer, H. (1976) · Clinica Chimica Acta · doi:10.1016/0009-8981(76)90318-1 · Cited by 8 · see citing works

Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis

Blondel, A., Kraoua, I., Marcelino, C., et al. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.106983 · Cited by 14 · see citing works

Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. residual activities toward natural and different synthetic substrates

Kytzia, H., HINRICHS, U., & Sandhoff, K. (1984) · Human Genetics · doi:10.1007/bf00291402 · Cited by 27 · see citing works